Jane Street’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.3M Buy
151,157
+144,020
+2,018% +$47.3M 0.01% 1145
2025
Q4
$2.5M Sell
7,137
-186,978
-96% -$63.2M ﹤0.01% 4391
2025
Q3
$62.7M Buy
194,115
+183,448
+1,720% +$57.1M 0.01% 831
2025
Q2
$4.15M Sell
10,667
-548
-5% -$220K ﹤0.01% 3266
2025
Q1
$4.88M Sell
11,215
-194,667
-95% -$78.1M ﹤0.01% 2976
2024
Q4
$75.9M Buy
205,882
+113,206
+122% +$47.4M 0.02% 529
2024
Q3
$48.2M Sell
92,676
-63,660
-41% -$34M 0.01% 708
2024
Q2
$84.7M Buy
156,336
+117,511
+303% +$62.1M 0.02% 458
2024
Q1
$20.1M Sell
38,825
-6,859
-15% -$3.41M ﹤0.01% 1179
2023
Q4
$21.5M Sell
45,684
-71,085
-61% -$32.9M 0.01% 1210
2023
Q3
$50.8M Buy
116,769
+998
+0.9% +$453K 0.02% 550
2023
Q2
$51.4M Buy
115,771
+50,720
+78% +$23.4M 0.02% 580
2023
Q1
$29.9M Buy
65,051
+38,951
+149% +$18.5M 0.01% 757
2022
Q4
$13.4M Sell
26,100
-75,806
-74% -$38.5M 0.01% 1334
2022
Q3
$46.3M Buy
101,906
+99,520
+4,171% +$47.6M 0.02% 554
2022
Q2
$1.15M Sell
2,386
-32,010
-93% -$15.8M ﹤0.01% 5223
2022
Q1
$16.9M Buy
34,396
+21,659
+170% +$9.9M 0.01% 1413
2021
Q4
$5.9M Sell
12,737
-630
-5% -$265K ﹤0.01% 2593
2021
Q3
$4.98M Sell
13,367
-89,050
-87% -$33.8M ﹤0.01% 2736
2021
Q2
$39.1M Buy
102,417
+50,923
+99% +$19.5M 0.02% 670
2021
Q1
$18.5M Buy
51,494
+21,436
+71% +$6.89M 0.01% 1044
2020
Q4
$9.65M Buy
30,058
+5,794
+24% +$1.78M ﹤0.01% 1442
2020
Q3
$6.52M Sell
24,264
-14,376
-37% -$3.87M ﹤0.01% 1587
2020
Q2
$10.2M Buy
38,640
+21,630
+127% +$5.77M 0.01% 1171
2020
Q1
$3.86M Buy
+17,010
New +$4.64M ﹤0.01% 1382
2019
Q4
Sell
-58,860
Closed -$16.2M 5198
2019
Q3
$14.1M Buy
58,860
+38,319
+187% +$10.5M 0.02% 460
2019
Q2
$5.8M Sell
20,541
-1,822
-8% -$498K 0.01% 947
2019
Q1
$6.42M Buy
22,363
+10,748
+93% +$3.11M 0.01% 957
2018
Q4
$3.05M Buy
11,615
+258
+2% +$70.9K 0.01% 1315
2018
Q3
$3.11M Sell
11,357
-29,711
-72% -$7.71M 0.01% 1459
2018
Q2
$9.78M Buy
41,068
+30,335
+283% +$7.02M 0.02% 625
2018
Q1
$2.36M Sell
10,733
-12,500
-54% -$2.94M 0.01% 1654
2017
Q4
$5.23M Buy
+23,233
New +$4.95M 0.02% 849
2017
Q3
Sell
-14,790
Closed -$2.81M 4567
2017
Q2
$2.78M Buy
14,790
+5,144
+53% +$924K 0.01% 1187
2017
Q1
$1.59M Sell
9,646
-24,691
-72% -$3.93M 0.01% 1571
2016
Q4
$4.94M Buy
34,337
+31,389
+1,065% +$4.2M 0.02% 673
2016
Q3
$369K Sell
2,948
-9,131
-76% -$1.18M ﹤0.01% 3085
2016
Q2
$1.59M Buy
12,079
+9,428
+356% +$1.29M 0.01% 1510
2016
Q1
$368K Buy
2,651
+509
+24% +$68K ﹤0.01% 2963
2015
Q4
$299K Sell
2,142
-1,270
-37% -$175K ﹤0.01% 3092
2015
Q3
$478K Sell
3,412
-98,066
-97% -$14.7M ﹤0.01% 2347
2015
Q2
$16.7M Buy
101,478
+86,992
+601% +$13.9M 0.11% 141
2015
Q1
$2.24M Buy
14,486
+12,882
+803% +$1.83M 0.02% 789
2014
Q4
$202K Sell
1,604
-3,081
-66% -$381K ﹤0.01% 2220
2014
Q3
$561K Buy
+4,685
New +$537K 0.01% 1335
2014
Q2
Sell
-63,717
Closed -$6.34M 2682
2014
Q1
$6.34M Buy
63,717
+61,166
+2,398% +$5.53M 0.07% 198
2013
Q4
$236K Sell
2,551
-21,260
-89% -$1.89M ﹤0.01% 1878
2013
Q3
$1.99M Buy
23,811
+15,334
+181% +$1.31M 0.02% 586
2013
Q2
$694K Buy
+8,477
New +$634K 0.01% 1178

Other funds holding ELV

Jane Street's ELV Position: Q1 2026 in Review

Jane Street increased its Elevance Health (ELV) stake by 2,018% in Q1 2026, buying an estimated $47.3M and bringing the position to 151,157 shares worth $44.3M. The position accounts for 0.01% of the portfolio, ranked #1145.

Jane Street first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $84.7M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Jane Street held 151,157 shares of Elevance Health worth $44.3M as of Q1 2026.
  • Jane Street bought 144,020 Elevance Health shares in Q1 2026, an estimated $47.3M.
  • Elevance Health made up 0.01% of Jane Street's portfolio in Q1 2026, its #1145 holding.
  • Jane Street first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
  • Jane Street's Elevance Health position peaked at $84.7M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.